Skip to content
Sunday, October 19, 2025
  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
Just News Now

Just News Now

  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
You are Here
  • Home
  • ISSARPharma

Tag: ISSARPharma

English Health Press Release

ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs

April 29, 2021

ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based

ISSARPharma, PeptidebasedNCEs, PNN

Recent Posts

  • ‘Ek Deewane Ki Deewaniyat’ – Love, Obsession … and a Dash of Censorship Drama
  • From BrahMos to AI Health Diplomacy: India’s Bold Play 2025
  • Another Light Counselling Spreads Warmth This Diwali with Free Sessions for Those Facing Loneliness
  • Chandan Healthcare Expands Presence with Two New Diagnostic Centres in New Delhi and Bhopal
  • Cupid Limited Achieves CE (EU IVDR) Certification for Pregnancy And Syphilis Test Kits, Paving the Way for Global Expansion in The Multibillion US Dollar IVD Market
  • Patil Automation Bags INR 10.82 Crore Order for Onsite Assembly Line Installation
  • PVL 2025: Calicut Heroes Clinch First win, Outplay Kolkata Thunderbolts 3–0
  • Priyanka Sharma Launches “ScrollControl” Initiative at ISAC CopConnect Round Table on Cyber Resilience
  • How KRIGAT Is Transforming Physiotherapy and Human Performance with AI
  • Mehai Technology’s Rs. 74.11 crore Rights Issue concludes, oversubscribed by 143.6%

Mail us : [email protected]

All Rights Reserved 2023.
Proudly powered by WordPress | Theme: Recent News by Candid Themes.